法国医疗监督机构卫生安全和健康产品委员会（l'Afssaps）劝告那些服用过治疗糖尿病的药物美蒂拓的患者接受心脏瓣膜损伤检查。
The French medical watchdog agency l'Afssaps has recently recommended that patients who took diabetes drug mediator should get tested for heart value damage.
法国医疗监督机构卫生安全和健康产品委员会（l'Afssaps）劝告那些服用过治疗糖尿病的药物美蒂拓的患者接受心脏瓣膜损伤检查。
The French medical watchdog agency l'Afssaps has recently recommended that patients who took diabetes drug mediator should get tested for heart value damage.
应用推荐